A detailed history of Notis Mc Conarty Edward transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Notis Mc Conarty Edward holds 9,335 shares of BMY stock, worth $453,494. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,335
Previous 10,135 7.89%
Holding current value
$453,494
Previous $549,000 29.51%
% of portfolio
0.15%
Previous 0.22%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $32,200 - $42,392
-800 Reduced 7.89%
9,335 $387,000
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $161,932 - $183,600
-3,375 Reduced 24.98%
10,135 $549,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $335,239 - $400,032
-6,915 Reduced 33.86%
13,510 $693,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $63,679 - $71,203
-1,100 Reduced 5.11%
20,425 $1.19 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $54,784 - $64,872
-800 Reduced 3.58%
21,525 $1.55 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $9 - $5,763
-75 Reduced 0.33%
22,325 $1.59 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $32,543 - $38,120
550 Added 2.52%
22,400 $1.33 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $44,505 - $50,054
750 Added 3.55%
21,850 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $43,305 - $49,072
-750 Reduced 3.43%
21,100 $1.31 Million
Q3 2020

Oct 28, 2020

SELL
$57.43 - $63.64 $57,142 - $63,321
-995 Reduced 4.36%
21,850 $1.32 Million
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $50,434 - $58,962
-920 Reduced 3.87%
22,845 $1.34 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $4,640 - $6,743
-100 Reduced 0.42%
23,765 $1.33 Million
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $180,600 - $235,577
3,670 Added 18.17%
23,865 $1.53 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $7,099 - $8,417
-166 Reduced 0.82%
20,195 $1.02 Million
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $23,425 - $25,903
-525 Reduced 2.51%
20,361 $924,000
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $27,072 - $32,280
-600 Reduced 2.79%
20,886 $997,000
Q4 2018

Jan 24, 2019

SELL
$48.76 - $63.23 $1,219 - $1,580
-25 Reduced 0.12%
21,486 $1.12 Million
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $11,984 - $13,796
-200 Reduced 0.92%
21,511 $1.36 Million
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $392,607 - $428,042
6,550 Added 43.2%
21,711 $1.33 Million
Q3 2017

Oct 26, 2017

BUY
$55.23 - $63.74 $837,342 - $966,362
15,161
15,161 $966,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $103B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Notis Mc Conarty Edward Portfolio

Follow Notis Mc Conarty Edward and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.